In drug development, preclinical development, also named preclinical studies and nonclinical studies, is a stage of research that begins before clinical trials (testing in humans) can begin, and during which important feasibility, iterative testing and drug safety data are collected  . The main goals of pre-clinical studies are to determine the safe dose for first-in-human study and assess a product's safety profile. Products may include new medical devices, drugs, gene therapy solutions and diagnostic tools . Typically, both in vitro and in vivo tests will be performed. Studies of a drug 's toxicity include which organs are targeted by that drug, as well as if there are any long-term carcinogenic effects or toxic effects on mammalian reproduction .
In drug development, preclinical development, also named preclinical studies and nonclinical studies, is a stage of research that begins before clinical trials (testing in humans) can begin, and during which important feasibility, iterative testing and drug safety data are collected , typically in laboratory animals . The main goals of preclinical studies are to determine a starting, safe dose for first-in-human study and assess potential toxicity of the product, which typically include new medical devices, prescription drugs, and diagnostics . Typically, both in vitro and in vivo tests will be performed. Studies of drug toxicity include which organs are targeted by that drug, as well as if there are any long-term carcinogenic effects or toxic effects causing illness .
A
, typically in laboratory animals
R
pre-clinical
preclinical
R
the
a starting,
R
a product's safety profile. Products may
potential toxicity of the product, which typically
R
drugs, gene therapy solutions and diagnostic tools
prescription drugs, and diagnostics
R
a drug 's
drug
R
on mammalian reproduction
causing illness